FAKTOR-OPTIONSSCHEIN - INSULET CORP. Stock

Certificat

DE000MG34B72

Real-time Bid/Ask 04:16:49 2024-05-29 EDT
8.13 EUR / 8.38 EUR +2.80% Intraday chart for FAKTOR-OPTIONSSCHEIN - INSULET CORP.
Current month-13.56%
1 month-20.89%
Date Price Change
24-05-28 8.03 +3.08%
24-05-27 7.79 -2.26%
24-05-24 7.97 -9.74%
24-05-23 8.83 +10.51%
24-05-22 7.99 +0.50%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 02:58 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INSULET CORPORATION
Issuer Morgan Stanley
WKN MG34B7
ISINDE000MG34B72
Date issued 2024-04-26
Strike 266.7 $
Maturity Unlimited
Parity 10.12 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.44
Lowest since issue 7.37
Spread 0.24
Spread %2.86%

Company Profile

Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. In addition, the group offers non-insulin subcutaneous drug delivery systems used in several therapeutic areas. Net sales break down by family of products as follows: - Insulin pump therapy systems (95.6%): continuous insulin management and delivery systems (Omnipod® and Omnipod DASH® brands) and automated insulin administration systems (Omnipod® 5 brand); - non-insulin drug administration systems (4.4%): in particular pre-filled syringes for the Neulasta® Onpro® kit (intended for the treatment of neutropenia in patients treated with chemotherapy). By the end of 2022, the group will have 2 production sites located in the United States and in China. The United States accounts for 72.2% of net sales.
Sector
-
More about the company

Ratings for Insulet Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Insulet Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
177.8 USD
Average target price
233.5 USD
Spread / Average Target
+31.31%
Consensus